GL1X · GenesisL1 explorer

Ligand · A1IGA

A1IGA · Lansoprazole sulfide

A1IGA, Lansoprazole sulfide (C16 H14 F3 N3 O S, 353.4 g/mol), in the MolNFT structures on GenesisL1: bound in 1 record (1 PDB entry). Every binding site with its residues within 4.5 Å, the residues it binds most and the ligands found with…

Component
A1IGA
Formula
C16 H14 F3 N3 O S
Class
ligand
Structures
1
PDB entries
1

Binding sites

A1IGA in 1 structure; the first of them:

  • 9FTZ · CIII2/CIV respiratory supercomplex from Mycobacterium smegmatis with lansoprazole sulfide · A1IGA N604 · binds CYS367, HIS368, PHE153, PHE156, THR169, GLY170, ALA173, ALA174 and 12 more

Residues it binds most

ALA 1, ILE 1, THR 1, MET 1, PHE 1, ASP 1, CYS 1, GLY 1, HIS 1, PRO 1 (residue and the binding sites it lines).

Found with

  • 3PE · 1,2-diacyl-sn-glycero-3-phosphoethanolamine
  • 7PH · (1R)-2-(dodecanoyloxy)-1-[(phosphonooxy)methyl]ethyl tetradecanoate
  • 9XX · (2S)-1-(hexadecanoyloxy)propan-2-yl (10S)-10-methyloctadecanoate
  • 9YF · (2R)-2-(hexadecanoyloxy)-3-{[(S)-hydroxy{[(1r,2r,3r,4r, 5R,6S)-2,3,4,5,6-pentahydroxycyclohexyl]oxy}phosphoryl]oxy}propyl (9S)-9-methyloctadecanoate
  • CDL · Cardiolipin
  • FES · Fe2/s2 (inorganic) cluster
  • HEA · Heme-A
  • HEC · Heme C
  • HEM · Protoporphyrin IX containing Fe
  • IZL · [(2~{R})-3-[[(1~{S},2~{R},3~{S},4~{S},5~{R},6~{R})-2-[(2~{R},3~{S},4~{S},5~{S},6~{R})-6-[[(2~{S},3~{S}, 4~{S},5~{S},6~{R})-6-[[(2~{S},3~{S},4~{S},5~{S}, 6~{R})-6-(hydroxymethyl)-3-[(2~{R},3~{S},4~{S},5~{S}, 6~{R})-6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-4,5-bis(oxidanyl)oxan-2-yl]oxymethyl]-3,4,5-tris(oxidanyl)oxan-2-yl]oxymethyl]-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-3,4,5-tris(oxidanyl)-6-[(2~{R},3~{S},4~{S},5~{S},6~{R})-3,4,5-tris(oxidanyl)-6-(undecanoyloxymethyl)oxan-2-yl]oxy-cyclohe
  • MQ9 · Menaquinone-9
  • PLM · Palmitic acid

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.